Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
20,317 results
- Observational Study Assessing Chronic Hepatitis C Management in Clinical Practice in Italy (Study P05488 AM1): Complete Statistical AnalysisIndependent statistical analysis of Observational Study Assessing Chronic Hepatitis C Management in Clinical Practice in Italy (Study P05488 AM1): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Observational Study of Anti-Reflux Surgery: Complete Statistical AnalysisIndependent statistical analysis of Observational Study of Anti-Reflux Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01624506).
- Observational Study of Botox® Treatment for Patients With Upper Limb Adult Spasticity: Complete Statistical AnalysisIndependent statistical analysis of Observational Study of Botox® Treatment for Patients With Upper Limb Adult Spasticity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Observational Study of Deferiprone (Ferriprox®) in the Treatment of Superficial Siderosis: Complete Statistical AnalysisIndependent statistical analysis of Observational Study of Deferiprone (Ferriprox®) in the Treatment of Superficial Siderosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Observational Study of Lumigan® 0.01% Treatment for Patients With Primary Open Angle Glaucoma or Ocular Hypertension: Complete Statistical AnalysisIndependent statistical analysis of Observational Study of Lumigan® 0.01% Treatment for Patients With Primary Open Angle Glaucoma or Ocular Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Observational Study of Nevirapine Extended Release in Human Immunodeficiency Virus (HIV) Patients in Daily Clinical Practice: Complete Statistical AnalysisIndependent statistical analysis of Observational Study of Nevirapine Extended Release in Human Immunodeficiency Virus (HIV) Patients in Daily Clinical Practice: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Observational Study on Hypothyroidism in Young Children Following Iodine Contrast Exposure: Complete Statistical AnalysisIndependent statistical analysis of Observational Study on Hypothyroidism in Young Children Following Iodine Contrast Exposure: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Observational Study to Assess the Frequency of Lidocaine Ineffectiveness in Hard-to-treat ADHD: Complete Statistical AnalysisIndependent statistical analysis of Observational Study to Assess the Frequency of Lidocaine Ineffectiveness in Hard-to-treat ADHD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Observational Study to Investigate the Long-term Effects of MIRCERA in Clinical Routine: Complete Statistical AnalysisIndependent statistical analysis of Observational Study to Investigate the Long-term Effects of MIRCERA in Clinical Routine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Observational Trial With Enbrel: Complete Statistical AnalysisIndependent statistical analysis of Observational Trial With Enbrel: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00488475).
- Observe the Effects of the Serkel Cranial Remolding Orthosis on Infants With Deformational Plagiocephaly: Complete Statistical AnalysisIndependent statistical analysis of Observe the Effects of the Serkel Cranial Remolding Orthosis on Infants With Deformational Plagiocephaly: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- OBSERVE-IVAIndependent statistical analysis of Trial Assessing the Effectiveness of Ivabradine Started at Discharge From the Observation Unit: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Obstructive Sleep Apnea in World Trade Center Responders: Complete Statistical AnalysisIndependent statistical analysis of Obstructive Sleep Apnea in World Trade Center Responders: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01753999).
- Obstructive Sleep Apnea Treatment to Improve Cardiac Rehabilitation: Complete Statistical AnalysisIndependent statistical analysis of Obstructive Sleep Apnea Treatment to Improve Cardiac Rehabilitation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02005445).
- Occurrence of Potential Bacterial and Viral Pathogens in Stable Chronic Obstructive Pulmonary Disease and During Acute Exacerbations of the Disease, in Asia Pacific: Complete Statistical AnalysisIndependent statistical analysis of Occurrence of Potential Bacterial and Viral Pathogens in Stable Chronic Obstructive Pulmonary Disease and During Acute Exacerbations of the Disease, in Asia Pacific: primary endpoint results, effect estimate…
- OCEANIndependent statistical analysis of Randomized Study of Obicetrapib in Combination With Ezetimibe: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04770389).
- OCEANIndependent statistical analysis of A Study of Melphalan Flufenamide (Melflufen)-Dex or Pomalidomide-dex for RRMM Patients Refractory to Lenalidomide: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- OCRIndependent statistical analysis of A Phase II Study of Oral Cyclophosphamide and Sirolimus (OCR) in Advanced Sarcoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- OCT Pilot in Esophagus: Complete Statistical AnalysisIndependent statistical analysis of OCT Pilot in Esophagus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03434834).
- OCTAVEIndependent statistical analysis of A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Ocular Characteristics in Contact Lens and Spectacle Wear: Complete Statistical AnalysisIndependent statistical analysis of Ocular Characteristics in Contact Lens and Spectacle Wear: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03913377).
- Ocular Comfort and OCT Observation of Post Lens Clearance and Ocular Tissue Compression: Complete Statistical AnalysisIndependent statistical analysis of Ocular Comfort and OCT Observation of Post Lens Clearance and Ocular Tissue Compression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Ocular Safety Of Patients Receiving Macugen For Neovascular Age Related Macular Degeneration: Complete Statistical AnalysisIndependent statistical analysis of Ocular Safety Of Patients Receiving Macugen For Neovascular Age Related Macular Degeneration: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Ocular Tolerability of Voclosporin Ophthalmic Solution Versus Restasis® in Subjects With Dry Eye Disease: Complete Statistical AnalysisIndependent statistical analysis of Ocular Tolerability of Voclosporin Ophthalmic Solution Versus Restasis® in Subjects With Dry Eye Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- ODEIIndependent statistical analysis of The Opening Doors to Early Intervention Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03625115).
- ODENIndependent statistical analysis of ODEN Trial: Option vs. Denali IVC Filters: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02201277).
- ODINIndependent statistical analysis of A Study to Compare Effectiveness and Safety of Darunavir/Ritonavir (DRV/Rtv) 800mg/100mg Once Daily Versus DRV/Rtv 600mg/100mg Twice Daily in Early Treatment-Experienced HIV-1 Infected Patients (ODIN): primary endpoint results,…
- Odiparcil For The Prevention Of Venous Thromboembolism: Complete Statistical AnalysisIndependent statistical analysis of Odiparcil For The Prevention Of Venous Thromboembolism: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00244725).
- ODYSSEY ESCAPEIndependent statistical analysis of Study of Alirocumab (REGN727/SAR236553) in Patients With Heterozygous Familial Hypercholesterolemia (HeFH) Undergoing Low-density Lipoprotein (LDL) Apheresis Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- ODYSSEY FH IIIndependent statistical analysis of Study of Alirocumab (REGN727/SAR236553) in Patients With heFH (Heterozygous Familial Hypercholesterolemia) Who Are Not Adequately Controlled With Their LMT (Lipid-Modifying Therapy): primary endpoint results, effect estimate with confidence…
- ODYSSEY HoFHIndependent statistical analysis of Study in Participants With Homozygous Familial Hypercholesterolemia (HoFH): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03156621).
- ODYSSEY OUTCOMESComplete statistical analysis of ODYSSEY OUTCOMES, the randomized phase 3 trial of alirocumab versus placebo after acute coronary syndrome, including time-to-event endpoints, hazard ratios, stratified log-rank testing, multiplicity, safety, and statistical interpretation.
- Ofatumumab and Bendamustine Followed by Maintenance Ofatumumab for Rituximab Relapsed Indolent B-cell Non-Hodgkin’s Lymphoma (B-NHL): Complete Statistical AnalysisIndependent statistical analysis of Ofatumumab and Bendamustine Followed by Maintenance Ofatumumab for Rituximab Relapsed Indolent B-cell Non-Hodgkin's Lymphoma (B-NHL): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Ofatumumab and Dinaciclib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or B-Cell Prolymphocytic Leukemia: Complete Statistical AnalysisIndependent statistical analysis of Ofatumumab and Dinaciclib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or B-Cell Prolymphocytic Leukemia: primary endpoint results, effect estimate with confidence interval,…
- Ofatumumab and Fresh Frozen Plasma in Patients With Chronic Lymphocytic Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Ofatumumab and Fresh Frozen Plasma in Patients With Chronic Lymphocytic Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Ofatumumab for Minimal Residual Disease (MRD) and Maintenance Therapy: Complete Statistical AnalysisIndependent statistical analysis of Ofatumumab for Minimal Residual Disease (MRD) and Maintenance Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01258933).
- Ofatumumab Plus Bendamustine in Frontline and Relapsed Chronic Lymphocytic Leukaemia (CLL): Complete Statistical AnalysisIndependent statistical analysis of Ofatumumab Plus Bendamustine in Frontline and Relapsed Chronic Lymphocytic Leukaemia (CLL): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Ofatumumab With High Dose Methylprednisone Followed by Ofatumumab and Alemtuzumab in 17p CLL: Complete Statistical AnalysisIndependent statistical analysis of Ofatumumab With High Dose Methylprednisone Followed by Ofatumumab and Alemtuzumab in 17p CLL: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Off Clamp Randomization: Complete Statistical AnalysisIndependent statistical analysis of Off Clamp Randomization: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01732120).
- Office-sclerotherapy for Epistaxis Due to Hereditary Hemorrhagic Telangiectasia: Complete Statistical AnalysisIndependent statistical analysis of Office-sclerotherapy for Epistaxis Due to Hereditary Hemorrhagic Telangiectasia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01408732).
- OGX-427 in Metastatic Castrate-Resistant Prostate Cancer With Prostate-Specific Antigen Progression While Receiving Abiraterone: Complete Statistical AnalysisIndependent statistical analysis of OGX-427 in Metastatic Castrate-Resistant Prostate Cancer With Prostate-Specific Antigen Progression While Receiving Abiraterone: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- OHR-3Independent statistical analysis of Safety for Frequent Use Conditions of Hair Removal Device: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01348789).
- OHTSIndependent statistical analysis of Ocular Hypertension Treatment Study (OHTS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00000125).
- OIIndependent statistical analysis of Multicenter,Single-arm Study to Evaluate Efficacy, Safety, & Pharmacokinetics of Denosumab in Children w/ OI: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- OISO-1Independent statistical analysis of Comparison of Three Techniques for Ultrasound-guided Internal Jugular Cannulation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01966354).
- OKQ2Independent statistical analysis of One Key Question: Pilot Study at NorthShore: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03947788).
- OLAIndependent statistical analysis of Oligonucleotide Ligation Assay (OLA) Resistance Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01898754).
- Olanzapine for Prevention of Chemotherapy-induced Nausea and Vomiting in Children: A Multi-Centre Feasibility Study: Complete Statistical AnalysisIndependent statistical analysis of Olanzapine for Prevention of Chemotherapy-induced Nausea and Vomiting in Children: A Multi-Centre Feasibility Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Olaparib and Ramucirumab in Treating Patients With Metastatic or Locally Recurrent Gastric or Gastroesophageal Junction Cancer That Cannot Be Removed by Surgery: Complete Statistical AnalysisIndependent statistical analysis of Olaparib and Ramucirumab in Treating Patients With Metastatic or Locally Recurrent Gastric or Gastroesophageal Junction Cancer That Cannot Be Removed by Surgery: primary endpoint results, effect estimate with…
- Olaparib Before Surgery in Treating Participants With Localized Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Olaparib Before Surgery in Treating Participants With Localized Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03570476).